MarketFriction

Godavari Biorefineries Ltd

NSE GODAVARIB · BSE 544279 · Diversified FMCG
₹227.18 -2.08%
NSE close2026-10-01
52 week range224.00 - 353.00
Market cap₹1,211 Cr.
P/E41.7
IPO 2024 · -35% since Price band 20% Delivery 62.5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales239398615523321447580533431460564558
Expenses271353501535354411467527439417478557
Operating Profit-3245114-12-33361126-843861
OPM %-13%11%18%-2.3%-10%8%19%1.1%-1.8%9%15%0.1%
Other Income121131491-23-692
Interest201820202019131512101114
Depreciation151614131212131414141414
Profit before tax-651391-42-64896-22-571370-26
Tax %0%-201%28%-37%17%32%25%-28%-27%39%25%-25%
Net Profit-653865-26-75672-16-42853-19
EPS in Rs-15.539.1615.54-6.23-17.881.1314.06-3.13-8.131.6110.33-3.78
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,4591,5381,7022,0151,6871,8701,9882,013
Expenses1,3561,3811,5681,8671,5531,7661,8611,891
Operating Profit103158134147134104127122
OPM %7%10%8%7%8%6%6%6%
Other Income148671416-19-18
Interest6972607376724948
Depreciation4547485060505455
Profit before tax346323212-251
Tax %-24%41%40%38%1%1,421%23%
Net Profit427192012-2340
EPS in Rs0.976.474.554.682.93-4.570.690.03
Dividend Payout %0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%5%0%7%
Compounded Profit Growth%5%18%318%
Stock Price CAGR%%%-8%
Return on Equity%2%1%4%
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital42424242425151
Reserves385412431448459731737
Borrowings589569636736655490531
Other Liabilities418419625518836683733
Total Liabilities1,4341,4421,7341,7441,9921,9552,052
Fixed Assets735708667866850862885
CWIP17950172937129
Investments0000000
Other Assets6837251,0168601,1131,0551,038
Total Assets1,4341,4421,7341,7441,9921,9552,052
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity250130451971856171
Cash from Investing Activity-23-7-48-214-44-69-163
Cash from Financing Activity-226-121628-15164-6
Net Cash Flow12311-1013
Free Cash Flow223119-5-20130-656
CFO/OP242%82%34%135%140%6%136%
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days31403737412721
Inventory Days130146200137250195198
Days Payable123132176105195140146
Cash Conversion Cycle39556168958274
Working Capital Days-68132-142116
ROCE %12%9%9%7%6%7%
Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters63.31%63.31%63.31%63.31%63.31%63.31%63.31%
FIIs1.14%0.96%0.63%0.60%0.86%0.98%0.22%
DIIs14.88%14.17%13.98%11.98%11.16%10.39%10.02%
Public20.67%21.56%22.09%24.11%24.67%25.31%26.44%
No. of Shareholders1,00,68599,07896,21793,91591,34488,77789,419

Fundamentals

Market Cap₹ 1,211 Cr.
Current Price₹ 236
Stock P/E41.7
Book Value₹ 154
ROCE6.55 %
ROE4.28 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)7%
Compounded Profit Growth (TTM)318%
Consolidated figures.
Valuation
Market capRs 953 Cr
Enterprise valueRs 1,644 Cr
P/E (TTM)4331.19x
Price to book1.95x
Price to sales0.47x
EV / EBITDA15.77x
EV / EBIT33.70x
EV / sales0.82x
Price to cash flow4.84x
Earnings yield0.02%
Profitability
Operating margin (excl. other income)7.32%
Operating margin (incl. other income)7.67%
EBITDA margin5.18%
Pre-tax margin0.05%
Net profit margin0.01%
Net margin, latest quarter-3.46%
ROE4.08%
ROCE8.96%
ROA1.13%
ROE, 3-year average4.79%
ROCE, 3-year average9.76%
ROA, 3-year average1.41%
ROIC (approx.)2.55%
Tax rate38.17%
Other income / net worth1.46%
Growth
Sales growth (latest year)18.35%
Profit growth (latest year)2.83%
Sales CAGR, 3 years11.35%
Profit CAGR, 3 years69.12%
Sales growth QoQ-1.10%
Profit growth QoQ-136.54%
Sales growth YoY (latest quarter)4.62%
Per share
EPS (TTM)Rs 0.05
EPS (latest year)Rs 4.68
EPS (latest quarter)Rs -4.61
EPS, 3-year averageRs 5.24
Book value per shareRs 116.69
Sales per shareRs 479.84
Cash flow per shareRs 46.96
Free cash flow per shareRs 1.43
Efficiency
Asset turnover1.16x
Fixed asset turnover2.33x
Inventory turnover3.15x
Inventory days116 days
Debtor days37 days
Debtors turnover9.97x
Creditor days146 days
Cash conversion cycle74 days
Working capital days16 days
Leverage
Total debtRs 736 Cr
Cash and bankRs 45 Cr
Net debtRs 691 Cr
Debt to equity1.50x
Net debt / EBITDA6.63x
Interest coverage1.02x
Current ratio (filing 2026-03-31)1.13x
Quick ratio (filing 2026-03-31)0.25x
Trade payables (filing 2026-03-31)Rs 569 Cr
Owners' fund to total sources28.07%
Debt to assets42.21%
Cash flow
Cash from Operating Activity (latest year)Rs 197 Cr
Cash from Investing Activity (latest year)Rs -214 Cr
Cash from Financing Activity (latest year)Rs 28 Cr
Net Cash Flow (latest year)Rs 11 Cr
Free cash flow (latest year)Rs 6 Cr
FCFE (approx.: FCF + change in debt)Rs 106 Cr
Cash from ops / profit, 5 years18.88x
Sales to cash flow10.23x
Statement figures
Net sales (TTM)Rs 2,013 Cr
Net sales (latest year)Rs 2,015 Cr
Sales (latest quarter)Rs 558 Cr
Operating profit excl. other income (latest year)Rs 147 Cr
Operating profit (latest quarter)Rs 1 Cr
Other income (TTM)Rs -18 Cr
EBITDA (TTM)Rs 104 Cr
PBDT (TTM)Rs 56 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 12 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 20 Cr
Net profit (latest quarter)Rs -19 Cr
Depreciation (TTM)Rs 55 Cr
Depreciation (latest quarter)Rs 14 Cr
Interest (TTM)Rs 48 Cr
Cost of goods sold (latest year)Rs 1,636 Cr
Total expenditure (latest year)Rs 1,867 Cr
Total income (latest year)Rs 2,022 Cr
Share capitalRs 42 Cr
ReservesRs 448 Cr
Shareholders' fundsRs 489 Cr
Total assetsRs 1,744 Cr
Net blockRs 866 Cr
Capital work in progressRs 17 Cr
ReceivablesRs 202 Cr
InventoryRs 519 Cr
Other liabilitiesRs 518 Cr
Shares outstanding (crore)4.19
Ownership
Promoter holding63.31% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 1.95 is at the 12th percentile (median 2.27).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodGODAVARIBNifty 50Difference
1 week-4.8%-2.8% -2.0 pts
1 month-3.3%-6.8% +3.5 pts
3 months-16.5%-7.6% -8.9 pts
6 months-23.1%+0.4% -23.5 pts
1 year-14.8%-9.9% -4.9 pts
4 mutual fund schemes hold about ₹105 Cr. Over three months 0 bought more and 3 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
ICICI Pru ELSS-Tax Saver Fund0.33%48 -4%
HDFC Manufacturing Fund0.40%42 -6%
Bank of India Small Cap Fund0.46%15 -24%
HDFC Consumption Fund0.07%1 -57%

Red flags

F-score 6 of 8
explainLow interest cover Interest cover 1.4x in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹558 Cr +4.7% vs Jun 2025. Net loss ₹19 Cr.
Against our estimate for Jun 2026: sales +4.6%, profit -464.2% miss. Our estimate for Sep 2026: sales Rs 435 Cr, profit Rs -4 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Hindustan Unilever Ltd437,91739.728.4 %
ITC Ltd332,18416.838.9 %
Hindustan Foods Ltd7,24044.814.1 %
Davangere Sugar Company Ltd39548.65.52 %
No bulk or block deals on record.
No corporate actions on record.
DateTypeWhat it says
2026-10-02General UpdatesGeneral Updates-- The Mexican Patent Office has granted our patent application entitled "USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS
2026-09-29Shareholder meetingVoting results.
2026-09-28AppointmentAppointment of Mr Appointment/re-appointment of Directors.
2026-09-28Shareholder meetingProceedings of Annual General Meeting held on September 28, 2026
2026-09-28General UpdatesGodavari Biorefineries Limited has informed regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
2026-09-23Concall / analyst meetSchedule of meet
2026-09-16General UpdatesGeneral Updates Chinese Patent Office has granted our patent application entitled "USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS".
2026-09-05General UpdatesGeneral updates. that The European Patent Office has granted a patent application; Title: A Biofiller for Rubber Reinforcement
2026-09-04General UpdatesLetter sent to Shareholders.
2026-09-04Shareholder meetingNotice of Annual General Meeting to be held on September 28, 2026
2026-08-29LitigationReceived show cause notice
2026-08-21LitigationReceived show cause notice from Asst. Commissioner of Central GST
2026-08-13Concall / analyst meetTranscript
2026-08-11General UpdatesGeneral Updates-European Patent Office has granted our patent application entitled"PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME
2026-08-07Concall / analyst meetSchedule of meet
2026-08-07Concall / analyst meetLink of Recording
2026-08-06Investor PresentationInvestor Presentation
2026-08-05Press ReleaseA press release dated August 05, 2026, titled "Unaudited Financial Results for the Q1FY27".
2026-08-05Board meeting outcomeGodavari Biorefineries Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-23Disclosure under SEBI TakeovGodavari Biorefineries Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India...
2026-07-22Concall / analyst meetSchedule of meet
2026-06-30Director changeChange in Director(s) of the company.
2026-06-29Shareholder meetingVoting results.
2026-06-29Capacity additionCapacity addition
2026-06-16General UpdatesJapanese Patent Office granted our patent, "5-HYDROXY-1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Godavari Biorefineries Ltd?

Godavari Biorefineries Ltd (GODAVARIB) has a market capitalisation of Rs 1,211 Cr. at the 2026-10-01 close.

What is the P/E ratio of Godavari Biorefineries Ltd?

Godavari Biorefineries Ltd trades at a P/E of 41.7 on trailing twelve-month profit, at the 2026-10-01 close.

What were Godavari Biorefineries Ltd's latest quarterly results?

In the Jun 2026 quarter, Godavari Biorefineries Ltd sales was Rs 558 Cr (+4.7% vs Jun 2025) with a net loss of Rs 19 Cr.

What is the 52-week high and low of Godavari Biorefineries Ltd?

The 52-week high is Rs 353.00 and the 52-week low is Rs 224.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03